Sanofi's consumer health care results factored so little in its latest quarter that it wouldn’t have mentioned a brand in the category if not for its pending relaunch of OTC heartburn remedy Zantac with famotidine as the active ingredient.
The French pharma on 28 April, along with its first-quarter results including a 7.3% drop in consumer health sales to...